PetVivo Holdings IncOTC Pink - Current Information:PETV
- LAST PRICE0.6500
- TODAY'S CHANGE (%)0.0003 (0.0462%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.6100 / 0.6497
- Day Range
- 52 Week Range
- Volume27,107
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PETV |
|---|---|---|
| 09:38 ET | 1000 | 0.61 |
| 09:39 ET | 1000 | 0.6397 |
| 09:54 ET | 2000 | 0.6497 |
| 10:44 ET | 500 | 0.601 |
| 11:08 ET | 100 | 0.6497 |
| 11:51 ET | 1575 | 0.6497 |
| 01:39 ET | 10000 | 0.6497 |
| 02:09 ET | 10864 | 0.65 |
Jun 28, 2024
PetVivo Reports Reports Fiscal 2024 Results, from 4:41PM ET on Friday Jun 28, 2024 by Dow Jones
4:41PM ET on Friday Jun 28, 2024 by Dow JonesPetVivo Reports Reports Fiscal 2024 Results, from 4:41PM ET on Friday Jun 28, 2024 by Dow Jones
4:41PM ET on Friday Jun 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
PetVivo Holdings Inc | 12.9M | -0.8x | --- |
REMSleep Holdings Inc | 14.4M | -8.0x | --- |
Agape ATP Corp | 8.5M | -3.5x | --- |
Innovative Eyewear Inc | 7.3M | -0.4x | --- |
Predictive Oncology Inc | 7.7M | -0.4x | --- |
Sigyn Therapeutics Inc | 6.4M | -1.7x | --- |
Company Information
PetVivo Holdings, Inc. is a biomedical device company focused on the manufacturing, commercialization and licensing of medical devices and therapeutics for companion animals. The Company has developed a pipeline of products for the medical treatment of animals and people, with a portfolio of 21 patents that protect the Company’s biomaterials, products, production processes and methods of use. Spryng with OsteoCushion Technology, its flagship product, is a veterinarian-administered, intra-articular injectable designed for the management of lameness and other joint related afflictions, including osteoarthritis, in cats, dogs and horses. It also has a pipeline that includes several therapeutic devices for both veterinary and human clinical applications. The Company manufactures its products in an ISO 7 certified clean room manufacturing facility in Minneapolis using its patented and scalable self-assembly production process. The Company may establish strategic out-licensing partnerships.
Contact Information
- Headquarters
- 5251 Edina Industrial BlvdEDINA, MN, United States 55439
- Phone
- 952-217-4952
- Fax
- 775-884-9383
Executives
- Independent Chairman of the Board
- James Martin
- President, Chief Executive Officer, Director
- John Lai
- Chief Financial Officer
- Garry Lowenthal
- Chief Operating Officer
- Randall Meyer
- Vice President - Sales
- Bryan Monninger
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $12.9M |
|---|---|
Revenue (TTM) | $968.7K |
Shares Outstanding | 19.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.41 |
EPS | $-0.81 |
Book Value | $0.04 |
P/E Ratio | -0.8x |
Price/Sales (TTM) | 13.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,130.25% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
